Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2281
Source ID: NCT01191320
Associated Drug: Placebo
Title: Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT01191320/results
Conditions: Type 2 Diabetes Mellitus|Secondary Hypogonadism
Interventions: DRUG: Placebo|DRUG: Androxal
Outcome Measures: Primary: Change in HbA1C, The change in HbA1c from Baseline to 3 Months for each treatment arm, 3 months |
Sponsor/Collaborators: Sponsor: Repros Therapeutics Inc.
Gender: MALE
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 102
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2010-10
Completion Date: 2011-12
Results First Posted: 2014-07-24
Last Update Posted: 2014-07-24
Locations: Paradigm Clinical Research, Garden Grove, California, 92844, United States|Northern California Research Corp, Sacramento, California, 95821, United States|LABioMed, Torrance, California, 90502, United States|Lahey Clinic, Peabody, Massachusetts, 01960, United States|Affiliated Clinical Research, Las Vegas, Nevada, 89109, United States|Affiliated Clinical Research, Las Vegas, Nevada, 89144, United States|Dr. Bruce Gilbert, Great Neck, New York, 11021, United States|University Urology, New York, New York, 10016, United States|Mount Sinai School of Medicine, New York, New York, 10029, United States|Dr. Michael Werner, Purchase, New York, 10577, United States|Discovery Clinical Trials, Austin, Texas, 78758, United States|Research Across America, Carrollton, Texas, 75010, United States|TX Urology Associate, Houston, Texas, 77024, United States|Centex Research, Houston, Texas, 77062, United States|Dr. Rakesh Patel, Houston, Texas, 77095, United States|Protenium Clinical Research, Hurst, Texas, 76054, United States|R/D Clinical Research, Lake Jackson, Texas, 77566, United States|Cetero Research, San Antonio, Texas, 78229, United States
URL: https://clinicaltrials.gov/show/NCT01191320

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress